Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05959564 · ClinicalTrials.gov registry record · NA
A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 456
- Enrollment target
NCT05959564: Completed NA study, sponsored by University of Maryland, College Park.
NCT05959564 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 456 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05959564, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 456 participants
- Enrollment target
Study Summary
The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will inform future communication interventions for reducing vaccine hesitancy among African American parents.
Primary Outcome
Participants' attitudes toward HPV vaccination were measured by seven questions such as "The HPV vaccine is beneficial for adolescents." The responses were recorded on 1 (strongly disagree) to 5 (strongly agree) scales. Final score was the average of all 7 questions.
Interventions
- BEHAVIORAL Personalized Chatbot Intervention
- BEHAVIORAL Non-Personalized Chatbot Intervention
- BEHAVIORAL No Chatbot Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2023-07-26 |
| Est. Completion | 2023-08-08 |
| Phase | NA |
What the finished NCT05959564 record still lists
NCT05959564 is an interventional study that assigns participants to a tested intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 3 interventions - of which Personalized Chatbot Intervention is the first listed.
NCT05959564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05959564 about?
NCT05959564 is a clinical study titled "A Chatbot Intervention for Reducing HPV Vaccine Hesitancy". The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will infor...
What is the current status of trial NCT05959564?
This trial is currently completed. It is a NA study. The enrollment target is 456 participants. The study started on 2023-07-26. Estimated completion is 2023-08-08.
What interventions are being tested in trial NCT05959564?
The interventions under investigation include: Personalized Chatbot Intervention (BEHAVIORAL), Non-Personalized Chatbot Intervention (BEHAVIORAL), No Chatbot Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05959564?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05959564's enrollment target sits among peer trials
456 224th of 2000 higher than 1,777 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04462302 · 456 participants · NA
An Internet-based Program to Help Cancer Survivors Manage Pain
- NCT05820919 · 456 participants · NA
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- NCT06254612 · 456 participants · Phase 2
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
- NCT06457841 · 456 participants · NA
Stress and Resilience
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI